Pfizer forecast 2025 revenue and earnings in line with market expectations, despite a $1 billion hit from the redesign of federal drug benefits.
Related Posts
WPP Returns to Growth, Beating Expectations
WPP reported a surprise rise in organic revenue for the third quarter, returning to growth after declines in previous quarters, as it benefited from higher […]
DBS Names CEO Successor
The Singapore banking heavyweight also raised guidance and reported a quarterly profit beat.
Zara Owner Inditex Posts Higher Sales Amid Fierce Low-Cost Competition
Inditex reported an increase in sales at the start of its final quarter, helped by its fall and winter collections and despite intense competition in […]